ReviewDrugs & aging2020

The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.

Sarah Sammons et al.PubMed ↗Publisher ↗

No numbers read from the abstract.